SAB Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LMR PARTNERS LLP | 02/14/2025 | 539,588 | $40,631 | 100.00% | 5.83% |
| YAKIRA CAPITAL MANAGEMENT, INC. | 02/13/2025 | 93,230 | $7,020 | -14.06% | 1.01% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 62,500 | $4,706 | 0.00% | 0.68% |
| HB WEALTH MANAGEMENT, LLC | 01/15/2025 | 50,001 | $3,870 | -83.87% | 0.54% |
| WALLEYE TRADING LLC | 02/13/2025 | 38,763 | $2,919 | 150.00% | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 8,655 | $651 | -44.23% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 1,633 | $122 | 100.00% | 0.02% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 1,072 | $80 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 48 | $4 | 0.00% | 0.00% |
| LMR PARTNERS LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of SAB Biotherapeutics, Inc.. The most heavily invested institutionals were:
LMR Partners LLP: 539,588
Yakira Capital Management, Inc.: 93,230
HB Wealth Management, LLC: 50,001
Walleye Trading LLC: 38,763
WOLVERINE ASSET MANAGEMENT LLC: 8,655
UBS Group AG: 1,633
9.50% of SAB Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 879,429 shares in the last 24 months. This purchase volume represents approximately $79,149 in transactions.